MicroSteer Information

At MicroSteer, we are unlocking the full potential of Endoscopic Submucosal Dissection (ESD) by transforming conventional endoscopes into precision resection systems. Our flagship platform, FALCON, solves the primary challenges of ESD for complex lesions by providing physicians with sub-millimeter precision steering of the electrosurgical knife directly at the tip of the endoscope. By adding an unprecedented level of control, FALCON makes advanced lesion resection safer, highly predictable, and accessible to a broader range of healthcare providers and patients. The Global Opportunity: • Over 80 Million GI endoscopy procedures are performed annually worldwide. • Over 2.75 Million complex GI lesions require advanced treatment annually worldwide. • High technical complexity and steep learning curves historically limit widespread ESD adoption. Why FALCON Matters: • Clinical Impact: Improves patient outcomes and reduces complex procedure times by 30%. • Seamless Integration: Features a plug-and-play platform that integrates effortlessly into existing hospital workflows. • Cost-Effective: Requires zero capital equipment and enables traction via an optional working channel, maximizing utility without budget strain. Company & Institutional Backing: Founded in 2023, MicroSteer Ltd. is a privately held Israeli medical device startup. We are proudly supported by the Israel Innovation Authority and backed by investment from NGT Healthcare II—a leading life sciences and medical device venture capital fund. Our world-class leadership team and global Scientific Advisory Board bring decades of combined commercialization and clinical expertise from Motus GI (NASDAQ: MOTS), Stryker GI, Mazor Robotics, Olympus (Gyrus-ACMI), King's College Hospital (London), and NTT Medical Center Tokyo. 🌐 Learn more about our vision, pipeline, and clinical milestones: ://microsteer.com